Please login to the form below

Not currently logged in
Email:
Password:

baloxavir marboxil

This page shows the latest baloxavir marboxil news and features for those working in and with pharma, biotech and healthcare.

Roche’s new flu pill Xofluza approved in US

Roche’s new flu pill Xofluza approved in US

The FDA has approved Roche’s new flu treatment Xofluza (baloxavir marboxil), the first new antiviral drug in nearly 20 years.

Latest news

  • Encouraging data for Roche flu drug ahead of FDA decision Encouraging data for Roche flu drug ahead of FDA decision

    complications. Baloxavir marboxil is a single-dose, investigational oral medicine, and has just achieved its primary endpoint in the CAPSTONE-2 trial comparing it with placebo and Tamiflu. ... If approved, baloxavir marboxil will be the first single-dose

  • Roche’s Tamiflu successor hits the mark in complicated flu Roche’s Tamiflu successor hits the mark in complicated flu

    Baloxavir marboxil met its primary objective and cut flu-related complications. Roche has reported a second pivotal data on a novel influenza drug – baloxavir marboxil – that it says is the first ... With baloxavir marboxil Roche now looks like it

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics